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ABSTRACT
Rheumatoid arthritis (RA) is a chronic disease characterized by inflammation of the joints and their lining or synovium. 
Previous studies showed that the synovium in RA patients is more hypoxic than normal synovium. Activated protein C 
(APC) has anticoagulant and anti-inflammatory effects and is highly expressed in the joints of RA patients. We examined 
the effect of APC on RA and normal synovial fibroblasts under hypoxic conditions. Human synovial fibroblasts were 
isolated from the synovial tissues of RA patients and normal controls and cells were exposed to recombinant APC under 
normoxic (21% oxygen) or hypoxic (1% oxygen) conditions. Cell proliferation was measured using MTT assays. Cell 
lysates and conditioned media were collected and assayed for matrix metalloproteinase (MMP)-2, MMP-9 and p38 using 
zymography and western blots. Proliferation of both normal and RA synovial fibroblasts dose-dependently increased 
after APC treatment in normoxic conditions. Under hypoxia, APC enhanced RA cell proliferation but had no effect on 
normal fibroblasts. MMP-2 production and activation were significantly augmented by APC in both cell types under 
normoxia and hypoxia conditions. However, activated MMP-2 was more reduced in cells under hypoxia than normoxia. 
APC substantially reduced the phosphorylation of p38 in normal and RA synovial fibroblasts under hypoxia. No difference 
in p38 phosphorylation was observed under normoxia. The receptor for APC, endothelial protein C receptor (EPCR), 
was elevated in normal fibroblasts under hypoxic conditions whereas in RA cells, EPCR was highly expressed under 
both normoxic and hypoxic conditions. We found that hypoxia enhanced the effect of APC on RA synovial fibroblasts 
through activation of MMP2 and inhibition of p38 phosphorylation. Our results suggested that APC may suppress joint 
destruction and progression of inflammation in a hypoxic RA environment.
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ABSTRAK
Reumatoid artritis (RA) adalah penyakit kronik yang dicirikan oleh keradangan sendi serta lapisan atau sinovium. 
Kajian terdahulu menunjukkan bahawa sinovium dalam pesakit RA lebih hipoksik daripada sinovium biasa. Protein yang 
diaktifkan C (APC) mempunyai kesan antikoagulan dan anti-radang yang sering terjadi dalam sendi pesakit RA. Kami 
mengkaji kesan APC pada RA dan sinovium fibroblas  normal dalam keadaan hipoksia. Sinovium fibroblas manusia telah 
diasingkan daripada tisu  sinovium pesakit RA dan kawalan normal, dan sel terdedah kepada APC rekombinan dalam 
keadaan oksigen (21% oksigen) atau hipoksik (1% oksigen). Proliferasi sel diukur menggunakan ujian MTT. Sel lisat 
dan media bersyarat dikumpulkan dan diuji pada matriks metaloproteinase (MMP) -2, MMP-9 dan p38 menggunakan 
zimografi dan western blots. Proliferasi pada kedua-dua dos biasa sinovium fibroblas dan RA meningkat bergantung 
pada rawatan APC dalam keadaan normosik. Di bawah hipoksia, APC meningkatkan percambahan sel RA tetapi tidak 
mempunyai kesan pada fibroblas biasa. Pengeluaran dan pengaktifan MMP-2 secara signifikan ditambah oleh APC dalam 
kedua-dua jenis sel di bawah keadaan normoksia dan hipoksia. Walau bagaimanapun, MMP-2 diaktifkan berkurangan 
dalam sel di bawah hipoksia daripada normoksia. APC secara substansial mengurangkan fosforilasi p38 dalam sinovium 
fibroblas  normal dan RA di bawah hipoksia. Tiada perbezaan dalam p38 fosforilasi diperhatikan di bawah normoksia. 
Reseptor untuk APC dan reseptor protein endotelium C (EPCR) dinaikkan pada fibroblas biasa di bawah keadaan hipoksik 
manakala dalam sel RA, EPCR dinyatakan di bawah kedua-dua keadaan normoksik dan hipoksik. Kami mendapati 
bahawa hipoksia meningkatkan kesan APC terhadap sinovium fibroblas RA melalui pengaktifan MMP2 dan perencatan 
p38 fosforilasi. Keputusan kami mencadangkan supaya APC dapat menghentikan kemusnahan sendi dan perkembangan 
keradangan dalam persekitaran RA hipoksik.
Kata kunci: Hipoksia; MMP-2; protein C diaktifkan; reumatoid artritis sinovium fibroblas 
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INTRODUCTION
Rheumatoid arthritis (RA) is a chronic autoimmune disease 
typically characterized by inflammation of the joints and 
their lining or synovium (Xue et al. 2007). RA chiefly 
affects joints and ultimately leads to joint tissue destruction. 
The symptoms of RA include deformed joints, pain and 
swelling. Therefore, early diagnosis and prevention of RA 
is important. However, precise causes of RA are not fully 
understood. Recent studies showed that the synovium in 
RA patients is more hypoxic than normal synovium and 
hypoxia-related signaling regulates pro-inflammatory 
pathways in RA (Akhavani et al. 2009; Gao et al. 2015). 
Furthermore, oxygen pressure is decreased in the RA 
synovium compared with normal joints (Paleolog 2009).
 Synovial hypoxia is a prominent feature of RA 
(Akhavani et al. 2009; Del Rey et al. 2010; Ryu et al. 
2014). Under hypoxic conditions, low oxygen levels are 
associated with expression of hypoxia-inducible factors 
(HIFs) and increased pro-inflammatory cytokines (Melillo 
2011). HIFs principally drive the cellular response under 
hypoxia, through interaction with hypoxia-responsive 
elements that leads to gene expression (Rankin & Giaccia 
2008). In particulars, HIFs are increased in RA-affected 
joints, HIFs increase inflammatory cell infiltration and 
inflammatory-mediated products such as p38 and nuclear 
factor-kappa B (NF-kB) (Konisti et al. 2012).
 Activated protein C (APC) results from conversion 
of protein C and has cytoprotective anti-inflammatory, 
anti-apoptotic, and anticoagulant activities (Danese et al. 
2010; McKelvey et al. 2014; Minhas et al. 2010). APC is 
triggered by the thrombin-thrombomodulin complex and 
appears on the endothelial cell surface (Jackson et al. 2014; 
Xue & Jackson 2015). The presence of the APC-specific 
receptor endothelial protein C receptor (EPCR) augments 
conversion to APC (Xue et al. 2007). EPCR is expressed 
on the surface of cells including endothelial cells and 
leukocytes (Lee et al. 2013; Seol et al. 2011; Thiyagarajan 
et al. 2007). EPCR is also expressed in other cells that have 
anti-inflammatory activity mediated by APC (Bouwens et 
al. 2013; Lee et al. 2013; Thiyagarajan et al. 2007; Xue 
et al. 2014). The anti-inflammatory activity of APC is 
associated with decreased leucocyte recruitment and pro-
inflammatory mediators (Esmon 2012; Minhas et al. 2010). 
APC reduces inflammation by regulating p38 activity by 
activating protease-activated receptor-2 (PAR-2) (Julovi et 
al. 2011). APC is elevated in RA synovial joints and fluids 
and co-localizes with matrix metalloproteinase (MMP)-2 
in the lining layer (Buisson-Legendre et al. 2004; Xue et 
al. 2014).
 MMP-2 is a member of the MMPs. Among this 
subfamily, the gelatinase subfamily includes MMP-2 and 
MMP-9 (Sela-Passwell et al. 2010). MMPs are key mediators 
of inflammation and RA (Bauvois 2012; Xue & Jackson 
2015). In addition, activation and expression of MMP-2 
are stimulated by APCs in endothelial cells and fibroblasts 
(Lee et al. 2013). Previous studies showed that MMP-9 is 
decreased by APC in the ischemic brain (Cheng et al. 2006). 
Furthermore, APC inhibits MMP-9 expression and stimulates 
MMP-2 activation and expression in synovial fibroblasts 
from RA patients and normal adults (Jackson et al. 2009; 
Xue et al. 2007, 2004). However, the effect of APC on RA 
and normal fibroblast cells under hypoxic conditions is not 
fully understood.
 To understand how synovial cells and chondrocytes 
behave in different oxygen tensions deep in the cartilage 
and during joint diseases such as RA, we examined APC 
effects on normal and RA synovial fibroblasts under 
normoxic (21% O2) and hypoxic (1% O2) conditions. 
Exposure to normoxia and hypoxia showed that APC 
treatment decreased phosphorylation of p38 in hypoxic 
conditions. Our results indicated that APC exerted a 
protective effect on RA synovial fibroblasts by inhibiting 
pro-inflammatory p38 and NF-kB and increasing anti-
inflammatory MMP-2 under hypoxic conditions.
MATERIALS AND METHODS
ISOLATION AND TREATMENT OF CELLS
Human synovial fibroblasts were isolated from the synovial 
tissues of RA patients during joint replacement surgery 
according to American College of Rheumatology criteria 
(Arnett et al. 1988). Tissues were minced and digested with 
2 mg/mL collagenase (Sigma-Aldrich, St. Louis, MO, USA) 
in Dulbecco’s modified Eagle medium (DMEM) containing 
100 U/mL penicillin/streptomycin, 10 mmol/L HEPES (all 
from Gibco BRL/Life Technologies, Carlsbad, CA, USA) and 
3.7 g/L NaHCO3 at 37°C for 3 h, followed by digestion 
with 0.25% trypsin and 0.02% ethylenediaminetetraacetic 
acid at 37°C for 30 min. Cells were cultured in DMEM 
containing 10% fetal bovine serum (ICN, Aurora, OH, 
USA) in 75 cm2 flasks at 37°C in a humidified 5% CO2 
atmosphere. Synovial cells were exposed to recombinant 
APC (Xigris; Eli Lilly, Indianapolis, IN) (0.1, 1, 10 and 
20 μg/mL) under normoxic (21%O2) and hypoxic (1% 
O2) conditions. Ethical approval was granted by the 
Royal North Shore Animal care and Ethics Committee 
and Northern Sydney Health Human Research Ethics 
Committee. 
CELL PROLIFERATION ASSAYS
Cell proliferation assays were performed as described 
previously (Julovi et al. 2011). Cells (2 × 103 cells/well) 
were seeded into 96-well microplates to a final volume of 
200 μL and incubated for 4 h to allow cells to attach. After 
preincubation for 12 h, cells were treated with APC for 72 
h in serum-free conditions under normoxic and hypoxic 
conditions. Cells were stained with 1 μg/mL crystal violet 
(Sigma-Aldrich) dissolved in phosphate buffered saline 
(PBS). Unbound dye was removed by washing with tap 
water. Bound crystal violet was solubilized with 0.1% 
sodium dodecyl sulfate (SDS) in PBS. Optical density of 
wells was determined at 550 nm wavelength. The results 
were expressed relative to control. 
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GELATINE ZYMOGRAPHY
In order to determine if APC directly activated gelatinases 
MMP-2 and MMP-9, cells were incubated with APC; 6-AQ (1 
μg/mL), a specific inhibitor of NF-kB activation; or a p38 
inhibitor (100 nM) for 72 h under normoxic and hypoxic 
conditions. MMP-2 activation in culture medium and cells 
was measured using gelatin zymography (Ruf 2004). 
Culture supernatants and cell lysates were loaded onto 10% 
SDS gels containing 0.5 mg/mL gelatin. Relative levels of 
MMP-2 were semiquantified using the Gel-Pro Analyzer 
(Media Cybernetics, Bethesda, MD).
WESTERN BLOTS
Cells were washed three times with PBS before lysis buffer 
(0.15 M NaCl, 0.01 mM PMSF, 1% NP-40, 0.02 M Tris, 6 
M urea/H2O) was added. Cell lysates were centrifuged 
at 10,000 × g for 15 min and total protein concentration 
was determined using BCA protein assay kits (Pierce 
Biotechnology, Rockford, IL, USA). Equal amounts of 
protein were separated by 8-15% SDS-polyacrylamide 
gel electrophoresis and Western blots were as previously 
described (Xue et al. 2005). Primary antibodies were 
rabbit antihuman EPCR (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), mouse antihuman MMP-9 (ab137867, 
Abcam®, UK) and MT1-MMP (Chemicon International, Inc., 
Temucula, CA, USA), rabbit antihuman phosphorylated p38 
(Santa Cruz Biotechnology) or mouse anti human NF-kB 
(Chemicon). Antihuman beta-actin was included to correct 
for unequal loading. 
IMMUNOFLUORESCENCE
Cells were cultured on gelatin (0.2% w/v)-coated four-
chamber glass slides and incubated with APC before 
processing for immunofluorescent staining as previously 
described (Riewald et al. 2002). Briefly, cells were fixed 
with cold acetone, blocked by 5% donkey serum in PBS and 
incubated with goat polyclonal antibody against protease-
activated receptor (PAR)-1 or mouse monoclonal antibody 
against PAR-2 (Santa Cruz Biotechnology) overnight at 
4ºC. After three washes with PBS, cells were incubated 
with antimouse IgG conjugated with Cy3 or antigoat IgG 
conjugated with fluorescein isothiocynate. Cells were 
washed with PBS and mounted in fluorescence medium. Cells 
were observed with an Eclispse 80i fluorescence microscope 
(Nikon Corporation, Tokyo, Japan).
HYPOXIC CONDITIONS
A hypoxic chamber was used to culture synovial fibroblasts 
at low oxygen tension (1% O2). For normoxic conditions 
(21% O2), synovial fibroblasts were incubated at 37ºC in 
a 95% humidified atmosphere with 5% CO2.
STATISTICAL ANALYSIS
Statistical differences were analyzed using Student’s t-test. 
ANOVA was used to compare means among three or more 
independent groups, followed by the Newman-Keuls 
post-hoc test. Results are displayed as mean ± standard 
deviation (SD).
RESULTS
APC INCREASES SYNOVIAL FIBROBLAST PROLIFERATION 
AND ACTIVATION OF MMP-2 UNDER HYPOXIA
In order to explore effects of APC under hypoxic conditions, 
we used normal synovial fibroblasts (NFb) and RA synovial 
fibroblasts (RAFb). We examined the effect of APC on cell 
proliferation under normoxia and hypoxia. In NFb cells, 
cell proliferation by APC treatments was increased under 
normoxic condition. Furthermore, cell proliferation of 
RAFb increased with APC under normoxic or hypoxic 
condition (Figure 1). When RAFb were treated with APC 
under hypoxic conditions, cell proliferation was increased 
(Figure 1(b)). APC treatment induced MMP-2 activation and 
expression in NFb and RAFb under normoxic and hypoxic 
conditions. However, APC induction of MMP-2 activation in 
hypoxic conditions was lower than in normoxic conditions 
(Figure 1).
MMP EXPRESSION REGULATED BY APC IS DIFFERENT 
UNDER NORMOXIC AND HYPOXIC CONDITIONS
We next examined APC-induced expression of MMPs MT1 
and MMP-9 in NFb and RAFb under normoxic and hypoxic 
conditions. MMP-9 expression was decreased by APC in 
NFb and RAFb under normoxic conditions. MMP-9 was 
slightly decreased after APC treatment of NFb under hypoxic 
conditions. MT1 MMP expression was not affected (Figure 
2(a)). In RAFb under hypoxic conditions, MMP expression 
was similar to NFb under hypoxic conditions (Figure 2). 
MMP expression differed between normoxic and hypoxic 
conditions: Under hypoxic conditions, MMP expression 
was reduced relative to normoxic conditions.
HYPOXIA AUGMENTS APC-INDUCED INFLAMMATORY 
MEDIATORS IN SYNOVIAL FIBROBLASTS
We next investigated whether APC regulated inflammatory-
mediated products in NFb and RAFb under hypoxic 
conditions. We examined if APC regulated PAR-1 and PAR-2 
in RAFb under hypoxic conditions. APC treatment increased 
PAR-1 and PAR-2 expression (Figure 3(a)). Subsequently, 
we tested expression of inflammatory-mediated products 
with APC under hypoxic conditions (Figure 3). In NFb 
under normoxic conditions, EPCR expression increased with 
APC treatment. Under hypoxic conditions, EPCR expression 
did not change with APC (Figure 3(b)). However, total 
EPCR expression was higher than in normoxic conditions. 
These experiments showed that under hypoxic conditions, 
APC treatment downregulated phosphorylated p38 and 
NF-kB expression (Figure 3(b) & 3(c)). Expression of 
phosphorylated p38 was observed only under hypoxic 
conditions (Figure 3). 
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FIGURE 1. Cell proliferation and matrix metalloproteinase activation of synovial fibroblasts by APC 
under normoxia and hypoxia. (a) and (b) proliferation of NFb and RAFb in response to APC treatment 
for 72 h under normoxia (21% O2) and hypoxia (1% O2) detected by crystal violet staining. Cell 
proliferation is expressed as percent of control (mean ± SD), (c) and (d) NFb and RAFb were treated 
with activated protein C (APC; 0.1, 1, 10 and 20 μg/mL) for 72 h under normoxia and hypoxia. Matrix 
metalloproteinase (MMP)-2 in culture supernatants by zymography, (e) and (f) Activated MMP-2 
expression in (c), (d) determined by densitometry. Three independent experiments 
show similar results. *p<0.05 versus normoxia by one-way ANOVA
FIGURE 2. Expression of MT1, MMP and MMP-9 in synovial fibroblasts with APC under normoxia and hypoxia. (a) and (b) 
NFb from normal patients and RAFb from RA were treated with activated protein C (APC; 0.1, 1, 10 and 20 μg/mL) for 72 h 
under normoxia (21% O2) and hypoxia (1% O2) and cell lysates and supernatants were collected for Western blots, (c) and 
(d) MMP-9 and MT1 MMP (intracellular) expression in (a), (e) and (f) and MMP-9 and MT1 MMP (intracellular) expression in 
(b) were measured by densitometry, Density was calculated as expression versus control. Three independent 
experiments showed similar results. *p<0.05 versus normoxia by one-way ANOVA
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ANTI-INFLAMMATORY ACTIVITY OF APC THROUGH P38 
PHOSPHORYLATION UNDER HYPOXIA
Under hypoxic conditions, p38 phosphorylation and NF-kB 
activation increased. These events were interdependent 
with inflammation. Thus, we tested the effect of APC on 
p38 and NF-kB under hypoxic conditions using the p38 
inhibitor SB203580 and the NF-kB inhibitor 6-AQ. We 
tested the activation of MMP-2 by APC under hypoxic 
conditions and found that active MMP-2 increased in 
culture supernatants with APC treatment, whereas APC did 
not affect MMP-2 activation in cells (Figure 4(a)). Similar 
results were observed with p38 or NF-kB inhibitor and APC 
treatment. We verified APC-related inflammatory mediator 
expression in RAFb under hypoxic conditions (Figure 4(b)). 
Under hypoxic conditions, MMP-9 reduction by APC was 
blocked by NF-kB inhibition. The effect of APC on RAFb 
under hypoxic condition was blocked by p38 inhibition. 
These results indicated that the effect of APC was via a 
p38-related pathway in RAFb under hypoxic conditions.
DISCUSSION
RA is a type of arthritis and a chronic autoimmune disorder 
(Huber et al. 2006; Xue et al. 2007). RA-related research 
is progressing steadily, however, the anti-inflammatory 
effect of APC on RA under hypoxic conditions is not fully 
understood. Previous reports show that APC reduces 
synovial hyperplasia in RA by inhibiting inflammatory 
signaling (Julovi et al. 2013). Our study focused on 
the effect of APC in hypoxic conditions. Our results 
showed that inflammatory signaling was downregulated 
by APC under hypoxic conditions. In these conditions, 
APC reduced p38 phosphorylation and NF-kB expression 
to inhibit inflammation. A previous study showed that 
under hypoxic conditions, p38 mitogen-activated protein 
kinase (p38MPAK) is essential for fibroblast proliferation 
and acts as a modulator of pro-inflammatory responses in 
rheumatological conditions (Mortimer et al. 2007). Indeed, 
if protease-activated receptors (PARs) are activated, they 
signal via p38 to induce immune responses (Julovi et 
al. 2011; Riewald & Ruf 2005). Thus, we expected that 
activation of p38 by APC under hypoxic conditions would 
be involved in the proliferation and anti-inflammatory 
response of RAFb. Our results were similar to our 
hypothesis (Figure 4(b)). Previous studies on APC and 
cell proliferation show APC inhibits proliferation (Julovi 
et al. 2013). However, our experiments showed that APC 
increased cell proliferation under normoxic and hypoxic 
conditions (Figure 1). These results confirmed previous 
studies (Xue et al. 2004). 
FIGURE 3. Change in protein levels in synovial fibroblasts with APC under normoxia and hypoxia. (a) PAR-1 and PAR-2 expression in 
RAFb in response to 1 μg/mL APC for 12 h, detected by immunofluorescence. Scale bars = 20 μm. (b) and (c) NFb and RAFb were treated 
with activated protein C (APC; 0.1, 1, 10 and 20 μg/mL) for 72 h under normoxia (21% O2) and hypoxia (1% O2) and protein in cell 
lysates was detected by Western blot, (d)-(i) Protein level shown in (b), (c) determined by densitometry, Density value was calculated 
as expression versus control. Three independent experiments showed similar results. *p<0.05 versus normoxia by one-way ANOVA
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 APC induced EPCR expression in NFb under normoxic 
conditions, whereas under hypoxic conditions, EPCR 
expression was generally increased (Figure 2(b) & 
2(c)). EPCR has high-affinity binding for APC and APC 
treatment increased EPCR expression. However, in hypoxic 
conditions, EPCR expression was increased overall.
 Of note, the change in MMPs with APC in normoxia 
was also observed in hypoxia. This evidence disproves 
that the anti-inflammatory effect of APC is reducing pain 
from RA by regulating MMP expression. In RAFb under 
hypoxic conditions, downregulation of MMP-9 by APC was 
stronger than normoxic conditions. APC activated MMP-2 
in both normoxia and hypoxia (Figure 4). These results 
were similar with both p38 and NF-kB inhibitors. These 
findings demonstrated that anti-inflammatory activity of 
APC was via p38 signaling in synovial fibroblasts under 
hypoxia.
We also observed APC-induced protein expression. Under 
normoxic conditions, MMP-9 expression was reduced by 
APC. Similar results were observed in hypoxic conditions 
(Figure 4(b)). However, in hypoxic conditions, reduced 
expression of MMP-9 by APC was blocked by p38 
inhibition. In addition, inhibition of NF-kB increased 
MMP-9 expression compared to no APC treatment. 
Our most important finding was that APC inhibited 
inflammation via p38-related signaling in RAFb under 
hypoxic conditions.
CONCLUSION
In summary, our findings provide features of APC in RA 
under hypoxic conditions. Hypoxia enhanced expression 
of EPCR and the effect of APC on RAFb via inhibition of 
p38 phosphorylation.
ACKNOWLEDGEMENTS
This paper was supported by research funds of Chonbuk 
National University in 2011.
REFERENCES
Akhavani, M.A., Madden, L., Buysschaert, I., Sivakumar, B., 
Kang, N. & Paleolog, E.M. 2009. Hypoxia upregulates 
angiogenesis and synovial cell migration in rheumatoid 
arthritis. Arthritis Research & Therapy 11(3): R64.
Arnett, F.C., Edworthy, S.M., Bloch, D.A., Mcshane, D.J., 
Fries, J.F., Cooper, N.S., Hunder, G.G. 1988. The 
American-Rheumatism-Association 1987 revised criteria 
for the classification of rheumatoid-arthritis. Arthritis and 
Rheumatism 31(3): 315-324.
Bauvois, B. 2012. New facets of matrix metalloproteinases 
MMP-2 and MMP-9 as cell surface transducers: Outside-in 
signaling and relationship to tumor progression. Biochimica 
Et Biophysica Acta-Reviews on Cancer 1825(1): 29-36.
Bouwens, E.A., Stavenuiter, F. & Mosnier, L.O. 2013. 
Mechanisms of anticoagulant and cytoprotective actions 
of the protein C pathway. Journal of Thrombosis and 
Haemostasis 11(Suppl 1): 242-253.
Buisson-Legendre, N., Smith, S., March, L. & Jackson, C. 
2004. Elevation of activated protein C in synovial joints 
in rheumatoid arthritis and its correlation with matrix 
metalloproteinase 2. Arthritis Rheum. 50(7): 2151-2156.
Cheng, T., Petraglia, A.L., Li, Z., Thiyagarajan, M., Zhong, Z., 
Wu, Z., Liu, D., Maggirwar, S.B., Deane, R., Fernández, 
J.A., LaRue, B., Griffin, J.H., Chopp, M. & Zlokovic, 
B.V. 2006. Activated protein C inhibits tissue plasminogen 
FIGURE 4. Involvement of NF-kB and p38 in activation of matrix metalloproteinases MMP-2 and 
MMP-9 by activated protein C. (a) RAFb were treated with a combination of activated protein C 
APC (10 μg/mL) and 6-AQ (1 μg/mL), a specific inhibitor of NF-kB activation, or a p38 inhibitor 
(100 nM) for 72 h under normoxia (21% O2) and hypoxia (1% O2). MMP-2 and MMP-9 were 
detected in culture supernatants and cell lysates by zymography and (b) RAFb were treated under 
the conditions described in (a). Protein was detected by Western blots
  1901
activator-induced brain hemorrhage. Nature Medicine 12(11): 
1278-1285.
Danese, S., Vetrano, S., Zhang, L., Poplis, V.A. & Castellino, 
F.J. 2010. The protein C pathway in tissue inflammation and 
injury: Pathogenic role and therapeutic implications. Blood 
115(6): 1121-1130.
Del Rey, M.J., Izquierdo, E., Usategui, A., Gonzalo, E., Blanco, 
F.J., Acquadro, F. & Pablos, J.L. 2010. The transcriptional 
response of normal and rheumatoid arthritis synovial 
fibroblasts to hypoxia. Arthritis Rheum. 62(12): 3584-3594.
Esmon, C.T. 2012. Protein C anticoagulant system-anti-
inflammatory effects. Seminars in Immunopathology 34(1): 
127-132.
Gao, W., McCormick, J., Connolly, M., Balogh, E., Veale, D.J. & 
Fearon, U. 2015. Hypoxia and STAT3 signalling interactions 
regulate pro-inflammatory pathways in rheumatoid arthritis. 
Annals of the Rheumatic Diseases 74(6): 1275-1283.
Huber, L.C., Distler, O., Tarner, I., Gay, R.E., Gay, S. & Pap, 
T. 2006. Synovial fibroblasts: Key players in rheumatoid 
arthritis. Rheumatology (Oxford) 45(6): 669-675.
Jackson, M.T., Moradi, B., Smith, M.M., Jackson, C.J. & Little, 
C.B. 2014. Activation of matrix metalloproteinases 2, 9, and 
13 by activated protein C in human osteoarthritic cartilage 
chondrocytes. Arthritis Rheumatol. 66(6): 1525-1536.
Jackson, M.T., Smith, M.M., Smith, S.M., Jackson, C.J., Xue, 
M. & Little, C.B. 2009. Activation of cartilage matrix 
metalloproteinases by activated protein C. Arthritis Rheum. 
60(3): 780-791.
Julovi, S.M., Shen, K., McKelvey, K., Minhas, N., March, L. & 
Jackson, C.J. 2013. Activated protein C inhibits proliferation 
and tumor necrosis factor alpha-stimulated activation of p38, 
c-Jun NH2-terminal kinase (JNK) and akt in rheumatoid 
synovial fibroblasts. Molecular Medicine 19: 324-331.
Julovi, S.M., Xue, M., Dervish, S., Sambrook, P.N., March, L. 
& Jackson, C.J. 2011. Protease activated receptor-2 mediates 
activated protein C-induced cutaneous wound healing via 
inhibition of p38. American Journal of Pathology 179(5): 
2233-2242.
Konisti, S., Kiriakidis, S. & Paleolog, E.M. 2012. Hypoxia-a key 
regulator of angiogenesis and inflammation in rheumatoid 
arthritis. Nature Reviews Rheumatology 8(3): 153-162.
Lee, Y.J., Jeong, J.K., Seol, J.W., Xue, M.L., Jackson, C. & 
Park, S.Y. 2013. Activated protein C differentially regulates 
both viability and differentiation of osteoblasts mediated by 
bisphosphonates. Experimental and Molecular Medicine 
45(2): e9.
McKelvey, K., Jackson, C.J. & Xue, M. 2014. Activated protein 
C: A regulator of human skin epidermal keratinocyte function. 
World Journal of Biological Chemistry 5(2): 169-179.
Melillo, G. 2011. Hypoxia: Jump-starting inflammation. Blood 
117(9): 2561-2562.
Minhas, N., Xue, M., Fukudome, K. & Jackson, C.J. 2010. 
Activated protein C utilizes the angiopoietin/Tie2 axis to 
promote endothelial barrier function. FASEB Journal 24(3): 
873-881.
Mortimer, H.J., Peacock, A.J., Kirk, A. & Welsh, D.J. 2007. p38 
MAP kinase: Essential role in hypoxia-mediated human 
pulmonary artery fibroblast proliferation. Pulmonary 
Pharmacology and Therapeutics 20(6): 718-725.
Paleolog, E.M. 2009. The vasculature in rheumatoid arthritis: 
Cause or consequence? International Journal of Experimental 
Pathology 90(3): 249-261.
Rankin, E.B. & Giaccia, A.J. 2008. The role of hypoxia-inducible 
factors in tumorigenesis. Cell Death & Differentiation 15(4): 
678-685.
Riewald, M., Petrovan, R.J., Donner, A., Mueller, B.M. & Ruf, 
W. 2002. Activation of endothelial cell protease activated 
receptor 1 by the protein C pathway. Science 296(5574): 
1880-1882.
Riewald, M. & Ruf, W. 2005. Protease-activated receptor-1 
signaling by activated protein C in cytokine-perturbed 
endothelial cells is distinct from thrombin signaling. Journal 
of Biological Chemistry 280(20): 19808-19814.
Ruf, W. 2004. Protease-activated receptor signaling in the 
regulation of inflammation. Critical Care Medicine 32(5): 
S287-S292.
Ryu, J.H., Chae, C.S., Kwak, J.S., Oh, H., Shin, Y., Huh, Y.H. 
& Chun, J.S. 2014. Hypoxia-inducible factor-2 alpha is an 
essential catabolic regulator of inflammatory rheumatoid 
arthritis. Plos Biology 12(6): e1001881. 
Sela-Passwell, N., Rosenblum, G., Shoham, T. & Sagi, I. 2010. 
Structural and functional bases for allosteric control of MMP 
activities: Can it pave the path for selective inhibition? 
Biochim Biophys Acta 1803(1): 29-38.
Seol, J.W., Lee, Y.J., Jackson, C.J., Sambrook, P.N. & Park, S.Y. 
2011. Activated protein C inhibits bisphosphonate-induced 
endothelial cell death via the endothelial protein C receptor 
and nuclear factor-kappaB pathways. International Journal 
of Molecular Medicine 27(6): 835-840.
Thiyagarajan, M., Cheng, T. & Zlokovic, B.V. 2007. Endothelial 
cell protein C receptor: role beyond endothelium? Circulation 
Research 100(2): 155-157.
Xue, M. & Jackson, C.J. 2015. Novel functions of the 
anticoagulant activated protein C in maintaining skin barrier 
integrity to impact on skin disease. Pathobiology 82(2): 
100-106.
Xue, M., March, L., Sambrook, P.N. & Jackson, C.J. 2007. 
Differential regulation of matrix metalloproteinase 2 and 
matrix metalloproteinase 9 by activated protein C: Relevance 
to inflammation in rheumatoid arthritis. Arthritis Rheum. 
56(9): 2864-2874.
Xue, M., Thompson, P., Kelso, I. & Jackson, C. 2004. Activated 
protein C stimulates proliferation, migration and wound 
closure, inhibits apoptosis and upregulates MMP-2 activity 
in cultured human keratinocytes. Experimental Cell Research 
299(1): 119-127.
Xue, M.L., Campbell, D., Sambrook, P.N., Fukudome, K. & 
Jackson, C.J. 2005. Endothelial protein C receptor and 
protease-activated receptor-1 mediate induction of a wound-
healing phenotype in human keratinocytes by activated 
protein C. Journal of Investigative Dermatology 125(6): 
1279-1285.
Xue, M.L., March, L., Sambrook, P.N., Fukudome, K. & Jackson, 
C.J. 2007. Endothelial protein C receptor is overexpressed in 
rheumatoid arthritic (RA) synovium and mediates the anti-
inflammatory effects of activated protein C in RA monocytes. 
Annals of the Rheumatic Diseases 66(12): 1574-1580.
Xue, M.L., Shen, K., McKelvey, K., Li, J., Chan, Y.K.A., Hatzis, 
V., Jackson, C.J. 2014. Endothelial protein C receptor-
associated invasiveness of rheumatoid synovial fibroblasts 
is likely driven by group V secretory phospholipase A(2). 
Arthritis Research & Therapy 16(1): R44.
Xue, M.L., Thompson, P., Kelso, I. & Jackson, C. 2004. Activated 
protein C stimulates proliferation, migration and wound 
closure, inhibits apoptosis and upregulates MMP-2 activity 
1902 
in cultured human keratinocytes. Experimental Cell Research 
299(1): 119-127.
Yang-Gyu Park, Jawun Choi, Inkyu Song, Sang-Youel Park & 
Jae-Won Seol*
Bio-Safety Research Institute
College of Veterinary Medicine
Chonbuk National University
Iksan, Jeonbuk 54596 
Republic of Korea 
Christopher J. Jackson
Sutton Arthritis Research Laboratories
Institute of Bone and Joint Research 
Kolling Institute of Medical Research
University of Sydney at Royal North Shore Hospital 
St. Leonards, NSW2065 
Australia
*Corresponding author; email: jwsseol@jbnu.ac.kr
Received:  4 March 2016
Accepted:  13 March 2017
